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Abstract We have previously reported on radiation-induction of 
ptk-3 in rat astrocyte culture [Sakuma et al. (1995) Radiat. Res. 
143, 1-7]. Ptk-3 was considered to be a rat version of human 
DDR (discoidin domain receptor). We cloned and analyzed 
genomic DNA of the DDR and its promoter region. We 
discovered that the promoter region contained a consensus 
sequence of the p53 tumor suppressor binding site. Adenovirus- 
mediated p53 transfection induced a high level of DDR mRNA in 
SAOS2 human osteosarcoma cells. These results indicate that 
DDR is up-regulated by the p53 protein. 
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1. Introduction 
DNA damage caused by ionizing radiation effects many 
genes which exert fundamental cellular functions including 
DNA repair, cell cycle checkpoint, and apoptosis. Previously, 
we identified a new receptor tyrosine kinase gene ptk-3 that 
was induced by ionizing radiation on rat astrocyte cultures 
using the mRNA differential display method [1]. Ptk-3 is con- 
sidered a membrane-associated r ceptor which has a factor 
VIII-like extracellular domain, glycine proline-rich transmem- 
brane domain, and a tyrosine kinase structure in the intracel- 
lular domain [2]. The human homologue of ptk-3 has been 
cloned by three independent groups, and named the discoidin 
domain receptor (DDR [3]), tyrosine receptor kinase E (TrkE 
[4]) and cell adhesion kinase (Cak [5]). Recently, Barker et al. 
[6] reported high level expression of DDR in human breast 
cancer cells as compared with more benign or normal cells, 
thus suggesting that DDR is involved with oncogenesis. How- 
ever, at present, neither the ligand of this unique receptor nor 
its function is known. 
In order to determine the biological functions of the recep- 
tor, we examined the genomic DNA structure of the human 
DDR gene and analyzed its promoter egion. Here, we show 
that the DDR promoter egion contains a p53 regulatory ele- 
ment, and that the gene is up-regulated by adenovirus- 
mediated p53 expression in the SAOS2 osteosarcoma cell line. 
2. Materials and methods 
2.1. Cloning and sequencing ofgenomic DNA of DDR 
An Sau3A partially digested human genomic DNA library (Clon- 
tech, CA, USA) was used as a PCR template to amplify each intron. 
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PCR primers were designed inside each pair of two Sau3A restriction 
sites according to the eDNA sequence of DDR (accession no. 
Ll1315). The PCR reaction was run in 20 ~tl of 10 mM Tris-HC1 
(pH 8.3), 50 mM KC1, 2 mM MgCI2, 0.25 mM dNTP, 0.4 ~M each 
primer and 2.5 units of recombinant Taq DNA polymerase (Takara, 
Ootsu, Japan). PCR consisted of 30 cycles at 95°C for 45 s, 62°C for 
1 min, 72°C for 2 min, and then 5 min elongation at 72°C. A Pro- 
moterFinder DNA Walking Kit (Clonetech) was also used to obtain 
clones having 5' and 3' ends, or longer introns. The first PCR was run 
in 20 Ixl of 1 X reaction buffer, 0.2 mM dNTP, 1.1 mM Mg(OAc)2, 0,2 
IxM adaptor primer (AP-1), 0.4 ~tM PM142 R (5'-AAAGATGA- 
CAGGGCCTCTGGTCCCAT-3'), 32 U/ml recombinant Tth DNA 
polymerase XL (Perkin Elmer, N J, USA), and 56 nM Tth Start Anti- 
body (Clontech). PCR consisted of 95°C for 1 min, then 35 cycles at 
95°C for 30 s, 68°C for 5 min, followed by 8 min elongation at 68°C. 
1 ~tl of a 1/100 dilution, of primary PCR products were used as a 
template for the second PCR reaction, under the same conditions as 
the primary one except for 0.2 ~tM adaptor primer (AP-2), 0.4 ~tM 
PM118R (5'-TGATCCCTCGGGCCTAAG-3'), and 20 PCR cycles. 
The PCR products were then cloned into the TA cloning vector 
pCRII (Invitrogen, CA, USA) and sequenced on an automated se- 
quencer Model 373A (Applied Biosystems, Chiba, Japan) with the 
DyeDeoxy Terminator Cycle Sequencing kit (Perkin Elmer, Chiba, 
Japan). 
2.2. Determination f chromosomal localization of DDR by radiation 
hybrid mapping 
In order to determine the chromosomal localization of the DDR, we 
used a new PCR-based technique designated as 'Radiation Hybrid 
Mapping' [7]. Two PCR primers were designed according to the nu- 
cleotide sequence of the 5' end of the genomic DDR sequence: 
PM82F (5'-TTTCTGCCATTGAGCATG-Y, corresponding to nt 
1489-1506) and PM75R (5'-CGGCTTAGAACAAACAAC-3', com- 
plementary to nt 1795-1812, accession o. U48705), and were used to 
amplify the DNA templates of the GeneBridge 4 panel (Research 
Genetics, Inc., Huntsville, AL). The PCR was run in a total reaction 
volume of 20 ~tl: 10 mM Tris-HC1, pH 8.3, 50 mM KCI, 0.2 mM 
dNTP, 2 mM MgC12, 0.4 ~tM PM82F, 0.4 gM PM 75R, 2.5 U Taq 
DNA polymerase (Perkin Elmer, NJ, USA) and 2 Ixl of each DNA 
template. The PCR cycle consisted of 94°C for 5 rain, then 35 cycles 
at 94°C for 1 rain, 60°C for 1 rain, 72°C for 1 min, followed by 5 min 
of after-extension at 72°C. 93 DNA templates of the GeneBridge 4
panel were amplified, and the resultant 324-bp PCR products were 
analyzed on 1% agarose gel electrophoresis with ethidium bromide 
staining. The PCR results were coded into binary form (10000 
00000 00100 00000 21000 10000 10010 10100 02020 10000 10110 
00001 01101 00010 00102 01100 01210 00000 001) according to the 
instruction manual and sent to the Whitehead Institute/MIT Center 
for Genome Research (E-maih http://www-genome.wi.mit.edu/). 
2.3. Adenovirus-mediated p53 transfer and Northern blotting 
Human osteosarcoma cell line SAOS2, which does not express WT 
p53 protein [8], was transfected with p53- or luciferase-expression 
adenovirus vector as described elsewhere [9]. Satisfactory expression 
of the p53 gene was confirmed with a reverse-transcription PCR (data 
not shown). 24 h or at the indicated times after transfection, total 
RNA was isolated by using RNazol (Cinna/Biotecx Laboratories, 
Friendswood, TX) and electrophoresed through formaldehyde/agar- 
ose gels, and transferred to Hybond-N membranes (Amersham, 
Bucks, UK). In order to detect he DDR mRNA signal, the partial 
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Fig. 1. Exon-intron organization of the genomic DDR gene. Filled boxes represent each exon. The tandem sequence of p53 protein binding 
consensus in the promoter egion (1539 bp upstream of the translation i itiation site) is shown. The TATA binding sequence is also shown 
(425 bp upstream of the translation i itiation site). The asterisk indicates mismatched bases compared with the p53 consensus sequence. 
cDNA sequence of DDR was amplified by PCR using two primers; 
PM1501 (5'-GTGTTGGAAGAGGAGCTGACGGTTCA-3' corre- 
sponding to nt 1501-1526), and PM2880 (5'-CACCGTGTTGAGTG- 
CATCCTCTGCCA-3', complementary to nt 2855-2880, GenBank 
accession o. L11315), subcloned into the TA cloning vector (Invitro- 
gen), and verified by sequencing. The membranes was prehybridized 
in Hybrisol I (Oncor, Gaithersburg, MD), followed by hybridization 
with the 32p-labeled EcoRI-digested fragment at 45°C overnight. After 
washing, the membranes were exposed to Kodak X-omat AR film at 
-70°C for 4 h to 2 days. As a control, the membranes were also 
probed with a p21 probe and G3PDH (glyceraldehyde-3-phosphate 
dehydrogenase, Clontech). The p21 probe contained a partial cDNA 
sequence which was amplified by PCR with two primers: PM21F (5'- 
ATGTCAGAACCGGCTGGGGATGTCCG-3', corresponding to nt 
76-101), and PM21MR (5'-TTAGGGCTTCCTCTTGGAGAAGAT- 
CA-3', complementary to nt 545-570, GenBank accession no. 
U03106), subcloned into the TA cloning vector (Invitrogen), and ver- 
ified by sequencing. 
2.4. Gel shift assay 
The oligonucleotides 5'-CAACAGGGTGAGCTGGTCCAGGCT- 
TATCTGATGT-3' (oligomer DDR-34F) and 5'-TTAAACATCA- 
GATAAGCCTGGACCAGCTCACCCT-3' (oligomer DDR-34R), 
corresponding to the DDR promoter sequences from -1548 to 
-1511 bp, were annealed to produce a double-stranded DNA probe. 
The wt-p53 protein was generated and purified according to [10]. For 
gel shift assay, 0.I ~tg wt-p53 protein was pre-incubated with mono- 
clonal anti-p53 antibodies Pab 421 or DO-I (Oncogene Science, Inc.), 
2 ~tg of poly(dI.dC) and binding buffer (I0 mM Tris-HC1 (pH 7.5), 
100 mM NaC1, 1 mM EDTA, 4% glycerol, 2 mM MgCI2, 1 mM 
dithiothreitol, 0.5 mM PMSF and 1 ~tg/ml pepstatin A) on ice for 
15 rain. 0.5 ng of 32P-end-labeled probe (1 × 105 cpm) was then added. 
After 90 min, the samples were subjected to electrophoresis n 6% 
non-denaturing polyacrylamide g ls using 0.25×TBE (25 mM Tris- 
HCI, 22 mM borate, 0.25 mM EDTA). The gels were then dried and 
exposed to Kodak X-omat AR film at -70°C for a few hours. 
3. Results 
3.1. Genomic DNA sequence of  DDR 
A total of 12010 bases were determined for the genomic 
DNA sequence of the DDR and deposited in GeneBank (ac- 
cession no. U48705). Fig. 1 shows a schematic representation 
of the structure of the gene, which consists of 15 exons and 14 
introns. Analysis of the promoter egion revealed a tandem 
repeat of the consensus binding sequence of the p53 tumor 
suppressor protein with one base mismatch (5'-PuPuPuC(A! 
T)(T/A)GPyPyPy-3', [11]) at 1114 bases upstream of the 
TATA box and 1539 bp upstream of the translation-initiation 
site. 
Analyzing the intron sequences revealed a 46-base long GT 
repeat in the third intron, which has not previously been re- 
ported as a dinucleotide repeat marker. 
3.2. Chromosomal localization of  DDR 
Fig. 2 shows the results of radiation hybrid mapping. The 
chromosomal assignment of the DDR was within 2.33 cR 
(centiRay) from D6S478 (Lod score > 3.0). The D6S478 mar- 
ker is located between D6S258 and D6S273 [12]. Although 
certain difficulties remain because of its rather incomplete 
correlation with the cytological and physical genetic maps, 
both D6S258 and D6S273 are known to be mapped to human 
chromosome 6p21.3 [12], which is consistent with the results 
of FISH analysis by Edelhoff et al. [13]. 
3.3. Northern blotting 
Fig. 3 shows the results of Northern blot analysis of the 
SAOS2 cell line, transfected with the adenovirus-mediated p53
expression vector (Ad-p53) in comparison with those with 
luciferase expression vector (Ad-Luc) as a control. Fig. 3 
also shows the time course after transfection. A strong signal 
of DDR mRNA was detected 24 and 36 h after transfection 
with the p53 expression vector in comparison with those with 
the luciferase expression vector, indicating a transcriptional 
activation of DDR gene by the p53 protein. In order to 
confirm that the p53-mediated transcriptional ctivation actu- 
ally occurred due to adenovirus transfection, the same blot 
was also hybridized with a p21 probe, since p21/waf-1 is 
well known as a downstream ediator of p53 [14]. The p21 
signal in the p53 expression vector transfected SAOS2 cells 
was markedly stronger than that of the luciferase control vec- 
tor. 
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Fig. 2. Results of radiation hybrid mapping. Chromosomal assignment of the DDR was within 2.33 cR (centiRay) from D6S478 (Lod score 
> 3.0), which is consistent with the results of Edelhoff et al. [13], 6p21.3. 
3.4. Gel shift assay 
Fig. 4 show the results of the gel shift assay. The arrow 
indicates the presence of the shifted bands which are thought 
to represent acomplex of the DDR probe and wt-p53 protein. 
The shifted bands disappear on incubation with excess cold 
probe, however, the supershifted bands which are thought o 
be a complex of the DDR probe, wt-p53 protein and the 
monoclonal antibodies Pab421, were not detected. The same 
results were obtained by using monoclonal antibodies DO-1 
instead of Pab421 (data not shown). 
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4. Discussion 
Evidence is accumulating that tumor suppressor protein 
p53 functions as a transcriptional f ctor and mediates induc- 
tion of various genes following DNA damage by ionizing 
radiation. Genes so far known to contain the p53 regulatory 
element include p21/WAF-1 [14,15], Gadd-45 [16], Bax [17], 
and the retinoblastoma susceptibility (Rb) gene [18]. Some 
of these (p21, Gadd45, Rb) are related to cell cycle arrest 
(checkpoint) and repair of damaged DNA. However, their 
precise function or role in radiation-induced DNA damage 
are unknown. 
Among these p53 regulatory genes, the chromosomal local- 
ization of p21 was reported to be 6p21.2 by E1-Deiry et al. 
[14]. Edelhoff et al. [13] reported the chromosomal localiza- 
tion of DDR to be 6p21.3. We confirmed this result by using 
radiation hybrid mapping, since Shelling et al. [19] reported 
that the chromosomal localization of EDDR1 (epithelial-spe- 
cific receptor kinase 1), which is considered to be a short 
transcript form of the DDR, was 6q16 as determined via 
FISH analysis. In addition to the p53-mediated induction of 
DDR, the near chromosomal localization of DDR to p21 sug- 
gests that p21 and DDR may share intimate or related func- 
tions downstream of the p53 cascade. Besides p21, HLA (hu- 
man leukocyte antigen) associated genes and TNF (tumor 
necrosis factor)-a/13 genes are also known to be located at 
6p21.3 (NCBI, OMIM Gene Map). 
The ptk-3 gene, the rat homologue of human DDR, is in- 
duced by ionizing radiation in normal rat astrocyte culture [1]. 
Taken together with the present results concerning the up- 
regulation of DDR, DDR/ptk-3 is considered to be a con- 
served gene which is transcriptionally activated by the induced 
p53 protein subsequent to DNA damage. Interestingly, Di 
Marco et al. [4] reported the expression of a short transcript 
form of DDR named trkE in normal human keratinocytes, 
and speculated from several lines of evidence that nerve 
growth factor (NGF) might be a candidate ligand for trkE. 
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Fig. 3. Northern blot analysis of SAOS2 cell line; time course after 
the transfection with adenovirus-mediated p53 expression vector 
(Ad-p53) in comparison with cells transfected with the luciferase x- 
pression vector (Ad-Luc). A strong signal of DDR mRNA was de- 
tected 24 and 36 h after transfection with p53 expression vector as 
compared with those with the luciferase xpression vector. In order 
to confirm the successful transfection of Ad-p53, the same blot was 
also hybridized with a p21 probe. The p21 signal in Ad-p53 trans- 
fected SAOS2 cells was markedly stronger than that of Ad-Luc. 
G3PDH was used as a loading control. 
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Fig. 4. Results of gel shift assay. Lane 1 shows the probe alone and 
the arrow indicates the presence of the shifted bands which are 
thought o be a complex of the DDR probe and wt-p53 protein 
(lane 2). The shifted bands disappeared on incubation with a 50- 
fold excess of cold probe (lane 4), however, supershifted bands 
which are thought o be a complex of the DDR probe, wt-p53 pro- 
tein and monoclonal ntibodies Pab421, were not detected (lane 3). 
NGF is a neurotrophic factor necessary for the survival of 
neuronal cells; in situations where NGF is lacking, cells 
may lead to apoptotic death [20]. Thus, p53-mediated DDR 
induction may be related to a modification of apoptotic el- 
lular process which occurs after exposure to DNA-damaging 
agents uch as ionizing radiation. Further investigation is war- 
ranted concerning the physiological and pathophysiological 
roles of DDR/ptk-3. 
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